Praxis Precision Medicines develops clinical-stage therapies for neurological disorders, targeting major unmet needs in CNS therapeutics.

For investors wondering if Leonardo DRS at around US$45.30 is offering good value or asking too much, this article breaks down what the current price might be indicating. The stock has seen a 4.5% ...